Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice

Neurobiology of Aging

Volumn 33, Issue 2, 2012, Pages 345-358

  Siegel, Jessica A ^a   Haley, Gwendolen E ^a   Raber, Jacob ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aging; Anxiety; Apolipoprotein E; Cognition

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; GLIAL FIBRILLARY ACIDIC PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; FEMALE; GENOTYPE; HIPPOCAMPUS; HOMOZYGOSITY; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPATIAL MEMORY; WESTERN BLOTTING;

AGING; ANIMALS; ANXIETY; APOLIPOPROTEINS E; BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS;

EID: 82755174052     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.03.002     Document Type: Article

References (73)

1. Abrari K., Rashidy-Pour A., Semnanian S., Fathollahi Y. Post-training administration of corticosterone enhances consolidation of contextual fear memory and hippocampal long-term potentiation in rats. Neurobiol. Learn. Mem 2009, 91:260-265.
2. Acevedo S.F., Piper B., Craytor M.J., Benice T.S., Raber J. Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children. Pediatr. Res. 2010, 67:293-299.
3. Acevedo S.E., McGinnis G., Raber J. Effects of 137Cs gamma irradiation on cognitive performance and measures of anxiety in Apoe-/- and wild-type female mice. Radiat. Res 2008, 170:422-428.
4. Acevedo S.F., Ohtsu H., Benice T.S., Rizk-Jackson A., Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc-/-) mice. Brain Res 2006, 1071:113-123.
5. Acevedo S.F., Pfankuch T., Ohtsu H., Raber J. Anxiety and cognition in female histidine decarboxylase knockout (Hdc(-/-)) mice. Behav. Brain Res 2006, 168:92-99.
6. Alexander D.M., Williams L.M., Gatt J.M., Dobson-Stone C., Kuan S.A., Todd E.G., Schofield P.R., Cooper N.J., Gordon E. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol. Psychol 2007, 75:229-238.
7. Amaral D.G. The primate amygdala and the neurobiology of social behavior: implications for understanding social anxiety. Biol. Psychiatry 2002, 51:11-17.
8. Andreano J.M., Cahill L. Glucocorticoid release and memory consolidation in men and women. Psychol. Sci 2006, 17:466-470.
9. Arendt T., Schindler C., Bruckner M.K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J. Neurosci 1997, 17:516-529.
10. Barclay L.L., Zemcov A., Blass J.P., McDowell F.H. Factors associated with duration of survival in Alzheimer's disease. Biol. Psychiatry 1985, 20:86-93.
11. Benice T.S., Rizk A., Kohama S., Pfankuch T., Raber J. Sex-differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuroscience 2006, 137:413-423.
12. Berteau-Pavy F., Park B., Raber J. Effects of sex and APOE epsilon4 on object recognition and spatial navigation in the elderly. Neuroscience 2007, 147:6-17.
13. -/- mice. Neuropsychopharmacology 2004, 29:441-449.
14. Bour A., Grootendorst J., Vogel E., Kelche C., Dodart J.C., Bales K., Moreau P.H., Sullivan P.M., Mathis C. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav. Brain Res 2008, 193:174-182.
15. Brichtova E., Kozak L. Apolipoprotein E genotype and traumatic brain injury in children - association with neurological outcome. Childs. Nerv. Syst 2008, 24:349-356.
16. Burvill P.W., Hall W.D., Stampfer H.G., Emmerson J.P. The prognosis of depression in old age. Br. J. Psychiatry 1991, 158:64-71.
17. Cahill L., Alkire M.T. Epinephrine enhancement of human memory consolidation: interaction with arousal at encoding. Neurobiol. Learn. Mem 2003, 79:194-198.
18. Caselli R.J., Reiman E.M., Hentz J.G., Osborne D., Alexander G.E. A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes. J. Neuropsychiatr. Clin. Neurosci 2004, 16:320-329.
19. Crawford F.C., Vanderploeg R.D., Freeman M.J., Singh S., Waisman M., Michaels L., Abdullah L., Warden D., Lipsky R., Salazar A., Mullan M.J. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002, 58:1115-1118.
20. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 2002, 51:68-80.
21. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci 1992, 15:353-375.
22. de Toledo M., Bermejo-Pareja F., Vega-Quiroga S., Munoz-Garcia D. Behavioural disorders in Alzheimer's disease. Data from a populational study. Rev. Neurol 2004, 38:901-905.
23. Deary I.J., Whiteman M.C., Pattie A., Starr J.M., Hayward C., Wright A.F., Carothers A., Whalley L.J. Cognitive change and the APOE epsilon 4 allele. Nature 2002, 418:932.
24. den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., Breteler M.M. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002, 59:746-748.
25. Domes G., Rothfischer J., Reichwald U., Hautzinger M. Inverted-U function between salivary cortisol and retrieval of verbal memory after hydrocortisone treatment. Behav. Neurosci 2005, 119:512-517.
26. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc 1997, 278:1349-1356.
27. Gallagher M., Burwell R., Burchinal M. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav. Neurosci 1993, 107:618-626.
28. Gilley D.W., Wilson R.S., Bennett D.A., Bernard B.A., Fox J.H. Predictors of behavioral disturbance in Alzheimer's disease. J. Gerontol 1991, 46:362-371.
29. Gochee P.A., Powell E.E., Purdie D.M., Pandeya N., Kelemen L., Shorthouse C., Jonsson J.R., Kelly B. Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C. Psychosomatics 2004, 45:49-57.
30. Greenwood P.M., Lambert C., Sunderland T., Parasuraman R. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study. Neuropsychology 2005, 19:199-211.
31. Greenwood P.M., Sunderland T., Putnam K., Levy J., Parasuraman R. Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: results from the NIMH BIOCARD study. Neuropsychology 2005, 19:830-840.
32. Grootendorst J., Bour A., Vogel E., Kelche C., Sullivan P.M., Dodart J.C., Bales K., Mathis C. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav. Brain Res 2005, 159:1-14.
33. Guangda X., Bangshun X., Xiujian L., Yangzhong H. Apovarepsilon(4) allele increases the risk for exercise-induced silent myocardial ischemia in non-insulin-dependent diabetes mellitus. Atherosclerosis 1999, 147:293-296.
34. Gustavson A., Cummings J. Assessment and treatment of neuropsychiatric Symptoms Internationaux Alzheimer'S Diseases. Current Clinical Neurology, Alzheimer's Disease; A Physician's Guide for Pratical Management 2004, Humana Press Totowa, New Jersey.
35. Jorm A.F. Does old age reduce the risk of anxiety and depression?. A review of epidemiological studies across the adult life span. Psychol. Med 2000, 30:11-22.
36. Kang J.H., Logroscino G., De Vivo I., Hunter D., Grodstein F. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol. Aging 2005, 26:475-484.
37. Knouff C., Hinsdale M.E., Mezdour H., Altenburg M.K., Watanabe M., Quarfordt S.H., Sullivan P.M., Maeda N. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Invest 1999, 103:1579-1586.
38. Lehtovirta M., Soininen H., Laakso M.P., Partanen K., Helisalmi S., Mannermaa A., Ryynanen M., Kuikka J., Hartikainen P., Riekkinen P.J. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. J. Neurol. Neurosurg. Psychiatry 1996, 60:644-649.
39. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
40. Martin R.J., Gwyther L.P., Whitehouse P.J. Special care unit research: ethical issues. Alzheimer Dis. Assoc. Disord 1994, 8:S360-S367.
41. Morris C.M., Massey H.M., Benjamin R., Leake A., Broadbent C., Griffiths M., Lamb H., Brown A., Ince P.G., Tyrer S., Thompson P., McKeith I.G., Edwardson J.A., Perry R.H., Perry E.K. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. J. Neural Transm. Suppl 1996, 47:205-218.
42. Nathoo N., Chetty R., van Dellen J.R., Barnett G.H. Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. Mol. Pathol 2003, 56:132-136.
43. Nicosia M., Prack M.M., Williams D.L. Differential regulation of apolipoprotein-E messenger RNA in zona fasciculata cells of rat adrenal gland determined by in situ hybridization. Mol. Endocrinol 1992, 6:288-298.
44. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14:149-167.
45. Plomin R., McClearn G.E., Smith D.L., Skuder P., Vignetti S., Chorney M.J., Chorney K., Kasarda S., Thompson L.A., Detterman D.K., Petrill S.A., Daniels J., Owen M.J., McGuffin P. Allelic associations between 100 DNA markers and high versus low IQ. Intelligence 1995, 21:31-48.
46. Porter V.R., Buxton W.G., Fairbanks L.A., Strickland T., O'Connor S.M., Rosenberg-Thompson S., Cummings J.L. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J. Neuropsychiatr. Clin. Neurosci 2003, 15:180-186.
47. Prack M.M., Nicosia M., Williams D.L., Gwynne J. Relationship between apolipoprotein E mRNA expression and tissue cholesterol content in rat adrenal gland. J. Lipid Res 1991, 32:1611-1618.
48. Pritchard A.L., Harris J., Pritchard C.W., Coates J., Haque S., Holder R., Bentham P., Lendon C.L. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:123-126.
49. Putman P., Van Honk J., Kessels R.P., Mulder M., Koppeschaar H.P. Salivary cortisol and short and long-term memory for emotional faces in healthy young women. Psychoneuroendocrinology 2004, 29:953-960.
50. Raber J., Chen S., Mucke L., Feng L. Corticotropin-releasing factor and adrenocorticotrophic hormone identified as potential mediators of central OB effects. J. Biol. Chem 1997, 272:15057-15060.
51. Raber J., Wong D., Buttini M., Orth M., Bellosta S., Pitas R.E., Mahley R.W., Mucke L. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. U S A 1998, 95:10914-10919.
52. Raber J., Akana S.F., Bhatnagar S., Dallman M.F., Wong D., Mucke L. Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations. J. Neurosci 2000, 20:2064-2071.
53. Raber J., Wong D., Yu G.Q., Buttini M., Mahley R.W., Pitas R.E., Mucke L. Apolipoprotein E and cognitive performance. Nature 2000, 404:352-354.
54. Raber J., Bongers G., LeFevour A., Buttini M., Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. J. Neurosci 2002, 22:5204-5209.
55. Raber J. Androgens, apoE, and Alzheimer's disease. Sci. Aging Knowl. Environ 2004, 2004:re2.
56. Raber J. Role of apolipoprotein E in anxiety. Neural Plast 2007, 91236.
57. Rabins P.V., Mace N.L., Lucas M.J. The impact of dementia on the family. J. Am. Med. Assoc 1982, 248:333-335.
58. Ramaswamy G., Xu Q., Huang Y., Weisgraber K.H. Effect of domain interaction on apolipoprotein E levels in mouse brain. J. Neurosci 2005, 25:10658-10663.
59. Rizk A., Curley J., Robertson J., Raber J. Anxiety and cognition in histamine H3 receptor-/- mice. Eur. J. Neurosci 2004, 19:1992-1996.
60. Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T., Raber J. apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiol. Aging 2005, 26:637-643.
61. Roses A.D. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol 1994, 53:429-437.
62. Roses A.D. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol 1995, 38:6-14.
63. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
64. Shaw P., Lerch J.P., Pruessner J.C., Taylor K.N., Rose A.B., Greenstein D., Clasen L., Evans A., Rapoport J.L., Giedd J.N. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007, 6:494-500.
65. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology 1994, 116:56-64.
66. Sullivan P.M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R.L., Quarfordt S.H., Maeda N. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem 1997, 272:17972-17980.
67. Sullivan P.M., Mace B.E., Maeda N., Schmechel D.E. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 2004, 124:725-733.
68. Turic D., Fisher P.J., Plomin R., Owen M.J. No association between apolipoprotein E polymorphisms and general cognitive ability in children. Neurosci. Lett 2001, 299:97-100.
69. van Meer P., Acevedo S., Raber J. Impairments in spatial memory retention of GFAP-apoE4 female mice. Behav. Brain Res 2007, 176:372-375. 10.1016/j.bbr.2006.10.024.
70. Villasana L., Acevedo S., Poage C., Raber J. Sex- and APOE isoform-dependent effects of radiation on cognitive function. Radiat. Res 2006, 166:883-891.
71. Villasana L., Poage C., van Meer P., Raber J. Passive avoidance learning and memory of 56Fe sham-irradiated and irradiated human apoE transgenic mice. Radiat. Biol. Radioecol. 2008, 48:191-194.
72. Wright R.O., Hu H., Silverman E.K., Tsaih S.W., Schwartz J., Bellinger D., Palazuelos E., Weiss S.T., Hernandez-Avila M. Apolipoprotein E genotype predicts 24-month bayley scales infant development score. Pediatr. Review 2003, 54:819-825.
73. Yu Y.W., Lin C.H., Chen S.P., Hong C.J., Tsai S.J. Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci. Lett 2000, 294:179-181.